Personal profile
Expertises
Endocrinology; Diabetes; Gut hormones; Glucagon
Main research areas
Diabetes; Gut hormones; Glucagon; Gut-derived glucagon; Glucagon-like peptide-1
Current research
Diabetic hyperglucagonaemia; extrapancreatic glucagon secretion; Anatomical and physiological delineation of gastrointestinally derived glucagon; Correlation bestween plasma and endothelial DPP-4 activity; Clearance of glucagon: Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia; GLP-1/GIP co-Activity in Individuals with type 2 Diabetes; Meal-time Administration of exenatide for Glycaemic control in type 1 diabetic Cases: A randomised, placebo-controlled trial; Elucidation of the pathophysiological consequences of hyperglucagonaemia in patients with type 2 diabetes using a glucagon receptor agonist
Potential conflicts of interest
Honorary for lectures and consultancy work: Novo Nordisk, Boehringer Ingelheim, Zealand Pharma
Advisoryboard: Eli Lilly
Participation as investigator in clinical trials: Novo Nordisk, Amgen
Research funding: Novo Nordisk, Zealand Pharma
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Research output
-
Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover study
Krogh, L. S. L., Helsted, M. M., Englund, A., Bergmann, N. C., Skov-Jeppesen, K., Nielsen, C. K., Hansen, C. P., Rosenkilde, M. M., Hartmann, B., Holst, J. J., Knop, F. K., Lund, A. B. & Gasbjerg, L. S., Jan 2026, In: Diabetes, Obesity and Metabolism. 28, 1, p. 275-286 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial
Nielsen, C. K., Pálsson, T. G., Forman, J. L., Lukacova, M., Jensen, B. A. H., Mathiesen, D. S., Englund, A., Gether, I. M., Johansen, N. J., Pedersen, M. G., Hartmann, B., Holst, J. J., Knop, F. K. & Lund, A. B., Mar 2026, In: EClinicalMedicine. 93, 103801.Research output: Contribution to journal › Journal article › Research › peer-review
-
Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study
Grøndahl, M. F. G., Rix, I., Garvey, L. F., Nielsen, C. K., Suppli, M. P., Willemoe, G. L., Kønig, M. J., Chabanova, E., Trammell, S. A. J., Grevengoed, T. J., Hartmann, B., Holst, J. J., Hansen, C. P., Lund, A. B. & Knop, F. K., 6 Mar 2026, (E-pub ahead of print) In: Diabetes.Research output: Contribution to journal › Journal article › Research › peer-review
-
Glucose-Dependent Effects of Exogenous Glucagon-Like Peptide-2 on Circulating Glucagon Levels in Healthy Men
Sørum, N. E., Magnussen, T., Hansen, N. L., Nielsen, C. K., Holst, J. J., Hartmann, B., Henriksen, K., Størling, J., Faber, J., Christensen, M. B., Lund, A. B. & Knop, F. K., 1 Feb 2026, In: Journal of the Endocrine Society. 10, 2, p. bvaf215 bvaf215.Research output: Contribution to journal › Journal article › Research › peer-review
-
Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study
Hoe, B., Heimbürger, S. M. N., Gasbjerg, L. S., Lanng, A. R., Lynggaard, M. B., Lund, A. B., Dela, F., Faber, J., Skov-Jeppesen, K., Engberg, S., Hartmann, B., Holst, J. J., Vilsbøll, T., Christensen, M. B., Dejgaard, T. F. & Knop, F. K., Mar 2026, In: Diabetes, Obesity and Metabolism. 28, 3, p. 1886-1898 13 p.Research output: Contribution to journal › Journal article › Research › peer-review